Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 5:6:7.
doi: 10.1186/s40695-020-00055-y. eCollection 2020.

Cortical and subcortical changes following sphenopalatine ganglion blocks in chronic migraine with medication overuse headache: a preliminary longitudinal study

Affiliations

Cortical and subcortical changes following sphenopalatine ganglion blocks in chronic migraine with medication overuse headache: a preliminary longitudinal study

Roger D Newman-Norlund et al. Womens Midlife Health. .

Abstract

Objective: The purpose of this pilot study was to investigate potential changes in brain morphology (cortical thickness and cortical/subcortical volume) accompanying a series of sphenopalatine ganglion (SPG) blockade treatments in chronic migraine with medication overuse headaches (CMw/MOH).

Background: Local anesthetization of the SPG via intranasal application is used for the treatment for multiple types of headache disorders, including CM. Our previous longitudinal fMRI study revealed improved network connectivity after such treatment. However, the impact of SPG blocks on cortical, subcortical gray matter volume and cortical thickness has yet to be assessed.

Methods: Using magnetic resonance imaging (MRI), cortical/subcortical volume were measured in 12 chronic migraine patients before and after a series of 12 SPG blocks administered over a 6-week period (2 per week). The average time between MRI assessments was 6 weeks. Targeted, within-subjects t-tests comparing pre-treatment and post-treatment values in specific apriori brain regions of interest, including the hippocampus, amygdala, basal ganglia, somatosensory cortex, temporal cortex and occipital cortex, were used to estimate the impact of repetitive SPG blocks treatment on brain morphology in CMw/MOH.

Results: Compared to baseline values, the number of moderate/severe headache days per month, HIT-6, PHQ-9 scores and allodynia scores were all significantly improved at the end of treatment. Analysis of MRI data revealed that the volume of the right hippocampus and the right palladium significantly decreased following SPG block treatment, while the volume of the left nucleus accumbens significantly increased following treatment. Cortical thickness in the left temporal pole and left lateral occipito-temporal gyrus significantly decreased following SPG block treatment.

Conclusion: Our results suggest SPG block treatment is associated with significant symptom improvement as well as significant structural brain changes in regions known to be associated with migraine and chronic pain processing in CMw/MOH.

Keywords: Chronic migraine; Cortical thickness; Medication overuse headache; Sphenopalatine ganglion; Voxel-based morphometry.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Subcortical structures exhibiting morphometric changes over the course of a 6-week SPG treatment. Volume significantly decreased in the hippocampus (yellow) and palladium (blue), and increased in the nucleus accumbens (orange)
Fig. 2
Fig. 2
Cortical structures exhibiting morphometric changes after SPG treatment. Over the course of the SPG treatment, cortical thickness decreased in the left temporal pole and the left lateral occipitotemporal sulcus. Ant = anterior, Post = posterior, L = left hemisphere

Similar articles

Cited by

References

    1. Lebovits AH, Alfred H, Lefkowitz M. Sphenopalatine ganglion block: clinical use in the pain management clinic. Clin J Pain. 1990;6:131–136. - PubMed
    1. Khan S, Schoenen J, Ashina M. Sphenopalatine ganglion neuromodulation in migraine: what is the rationale? Cephalalgia. 2014;34:382–391. - PubMed
    1. Schoenen J. Sphenopalatine Ganglion Stimulation in Neurovascular Headaches. Prog Neurol Surg. 2015;29:106–116. - PubMed
    1. Jürgens TP, May A. Role of Sphenopalatine ganglion stimulation in cluster headache. Curr Pain Headache Rep. 2014;18:433. doi: 10.1007/s11916-014-0433-4. - DOI - PubMed
    1. Tepper SJ, Rezai A, Narouze S, et al. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49:983–989. - PubMed

LinkOut - more resources